Literature DB >> 168152

Immunological relationship between delta herpesvirus of patas monkeys and varicells-zoster virus of humans.

A D Felsenfeld, N J Schmidt.   

Abstract

The Delta herpesvirus (DHV) which produced outbreaks of exanthematous disease in patas monkeys was shown to have a close immunological relationship to varicella-zoster (V-Z) virus of man. Immunization of rhesus monkeys with DHV or V-Z virus resulted in the development of neutralizing antibodies to both viruses and also in the production of complement-fixing antibodies to V-Z virus. Immunoglobulin M neutralizing antibody to V-Z virus was demonstrated in the serum of a rhesus monkey immunized with DHV, suggesting a primary antibody response rather than recall of antibody to a related virus. Convalescent-phase sera from human zoster cases had comparable levels of neutralizing antibody for both DHV and V-Z virus. Patas monkeys involved in an outbreak of DHV infection showed seroconversion to both DHV and V-Z virus by neutralization tests and to V-Z virus by complement fixation tests. The demonstration of the close antigneic relationship between DHV and V-Z virus suggests that DHV may be useful in an animal model system for studies on the latency and reactivation of V-Z virus.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168152      PMCID: PMC415278          DOI: 10.1128/iai.12.2.261-266.1975

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  A COMPLEMENT-FIXING ANTIGEN FOR VARICELLA-ZOSTER DERIVED FROM INFECTED CULTURES OF HUMAN FETAL DIPLOID CELLS.

Authors:  N J SCHMIDT; E H LENNETTE; C W SHON; T T SHINOMOTO
Journal:  Proc Soc Exp Biol Med       Date:  1964-05

2.  Pathology and clinical history of Delta herpesvirus infection in patas monkeys.

Authors:  R H Wolf; H F Smetana; W P Allen; A D Felsenfeld
Journal:  Lab Anim Sci       Date:  1974-02

3.  A varicella-like disease in macaque monkeys.

Authors:  G A Blakely; B Lourie; W G Morton; H H Evans; A F Kaufmann
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

4.  Syncytial giant cell focus assay for viruses derived from feline leukemia and a simian sarcoma.

Authors:  S R Rangan; P J Ueberhorst; M C Wong
Journal:  Proc Soc Exp Biol Med       Date:  1973-04

5.  Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.

Authors:  N J Schmidt; E H Lennette; R L Magoffin
Journal:  J Gen Virol       Date:  1969-04       Impact factor: 3.891

6.  Separation of infectious Varicella-Zoster virus from human embryonic lung fibroblasts.

Authors:  P A Brunell
Journal:  Virology       Date:  1967-04       Impact factor: 3.616

7.  Exanthematous disease in patas monkeys caused by a herpes virus.

Authors:  K McCarthy; E Thorpe; A C Laursen; C S Heymann; A J Beale
Journal:  Lancet       Date:  1968-10-19       Impact factor: 79.321

8.  Demonstration of rubella IgM antibody by indirect fluorescent antibody staining, sucrose density gradient centrifugation and mercaptoethanol reduction.

Authors:  B Forghani; N J Schmidt; E H Lennette
Journal:  Intervirology       Date:  1973       Impact factor: 1.763

9.  A virus disease of captive vervet monkeys (Cercopithecus aethiops) caused by a new herpesvirus.

Authors:  M J Clarkson; E Thorpe; K McCarthy
Journal:  Arch Gesamte Virusforsch       Date:  1967

10.  Studies of the delta herpesvirus isolated from the patas monkey (Erythrocebus patas).

Authors:  J P Ayres
Journal:  Lab Anim Sci       Date:  1971-10
View more
  13 in total

1.  Phosphonoacetic acid in the treatment of simian varicella.

Authors:  A D Felsenfeld; C R Abee; P J Gerone; K F Soike; S R Williams
Journal:  Antimicrob Agents Chemother       Date:  1978-09       Impact factor: 5.191

Review 2.  Simian varicella virus: molecular virology.

Authors:  Wayne L Gray
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Serological investigation of an outbreak of simian varicella in Erythrocebus patas monkeys.

Authors:  N J Schmidt; A M Arvin; D P Martin; E A Gard
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

4.  A simian varicella virus (SVV) homolog to varicella-zoster virus gene 21 is expressed in monkey ganglia latently infected with SVV.

Authors:  P Clarke; W L Matlock; T Beer; D H Gilden
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

5.  Inoculation of guinea pigs with varicella-zoster virus via the respiratory route.

Authors:  M A Walz-Cicconi; R M Rose; G J Dammin; T H Weller
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

6.  Antigenic relationships among several simian varicella-like viruses and varicella-zoster virus.

Authors:  A D Felsenfeld; N J Schmidt
Journal:  Infect Immun       Date:  1977-03       Impact factor: 3.441

7.  Ineffectiveness of adenine arabinoside and adenine arabinoside 5'-monophosphate in simian varicella infection.

Authors:  K F Soike; A D Felsenfeld; S Gibson; P J Gerone
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

8.  Mamu-A01/K(b) transgenic and MHC Class I knockout mice as a tool for HIV vaccine development.

Authors:  Jinliang Li; Tumul Srivastava; Ravindra Rawal; Edwin Manuel; Donna Isbell; Walter Tsark; Corinna La Rosa; Zhongde Wang; Zhongqi Li; Peter A Barry; Katharine D Hagen; Jeffrey Longmate; Don J Diamond
Journal:  Virology       Date:  2009-02-27       Impact factor: 3.616

9.  Activity of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil against simian varicella virus infections in African green monkeys.

Authors:  K F Soike; C Cantrell; P J Gerone
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

10.  Simian varicella virus infection of rhesus macaques recapitulates essential features of varicella zoster virus infection in humans.

Authors:  Ilhem Messaoudi; Alexander Barron; Mary Wellish; Flora Engelmann; Alfred Legasse; Shannon Planer; Don Gilden; Janko Nikolich-Zugich; Ravi Mahalingam
Journal:  PLoS Pathog       Date:  2009-11-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.